Healthcare - Biotechnology - NASDAQ - US
$ 0.5315
-8.41 %
$ 31.4 M
Market Cap
-0.71
P/E
Price Target
Average
1593.32%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
20.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Elevation Oncology, Inc.
Wall Street analysts predict an average 1-year price target for ELEV of $9 , with forecasts ranging from a low of $8 to a high of $10 .
ELEV Lowest Price Target
Wall Street Target
8 USD
1405.17%
ELEV Average Price Target
Wall Street Target
9 USD
1593.32%
ELEV Highest Price Target
Wall Street Target
10 USD
1781.47%
REVENUE FORECAST
Revenue Forecast Chart ELEV
EBIT FORECAST
EBIT Forecast Chart ELEV
NET INCOME FORECAST
Net Income Chart ELEV